Pinebridge Investments L.P. Sells 5,953 Shares of Encompass Health Co. (NYSE:EHC)

Pinebridge Investments L.P. reduced its position in Encompass Health Co. (NYSE:EHC) by 12.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 43,238 shares of the company’s stock after selling 5,953 shares during the period. Pinebridge Investments L.P.’s holdings in Encompass Health were worth $3,993,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of EHC. Charles Schwab Investment Management Inc. boosted its stake in Encompass Health by 0.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 644,764 shares of the company’s stock valued at $59,544,000 after acquiring an additional 4,345 shares in the last quarter. Central Pacific Bank Trust Division boosted its position in shares of Encompass Health by 15.1% in the 4th quarter. Central Pacific Bank Trust Division now owns 3,195 shares of the company’s stock worth $295,000 after purchasing an additional 418 shares in the last quarter. Merit Financial Group LLC purchased a new position in Encompass Health during the 4th quarter worth $374,000. MassMutual Private Wealth & Trust FSB increased its position in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after buying an additional 137 shares in the last quarter. Finally, US Bancorp DE raised its stake in Encompass Health by 9.6% in the fourth quarter. US Bancorp DE now owns 1,380 shares of the company’s stock valued at $127,000 after buying an additional 121 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Activity

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 2.10% of the company’s stock.

Wall Street Analysts Forecast Growth

EHC has been the topic of several recent analyst reports. Royal Bank of Canada restated an “outperform” rating and set a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. StockNews.com raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Friday. William Blair reissued an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Barclays raised their target price on Encompass Health from $118.00 to $129.00 and gave the stock an “overweight” rating in a research note on Friday. Finally, KeyCorp boosted their price target on Encompass Health from $120.00 to $122.00 and gave the company an “overweight” rating in a research note on Friday. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $110.88.

Encompass Health Trading Up 11.8 %

Encompass Health stock opened at $113.33 on Friday. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The firm has a market cap of $11.41 billion, a PE ratio of 25.41, a P/E/G ratio of 2.31 and a beta of 0.87. The stock’s 50 day simple moving average is $100.08 and its two-hundred day simple moving average is $98.51. Encompass Health Co. has a 12 month low of $82.09 and a 12 month high of $114.38.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.18. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The company had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st were given a dividend of $0.17 per share. The ex-dividend date of this dividend was Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.60%. Encompass Health’s dividend payout ratio is currently 15.25%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.